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Welcome to the first issue of Wounds UK with a new editorial team. I will be 
taking over from John Timmons as 
Editor and Karen Ousey is replacing 
Keith Cutting as Clinical Editor. Our 
thanks to them for all their hard work 
over the last few years and we hope 
to maintain their high standards.
Over the coming issues we hope 
to focus on several key objectives. 
These include:
8	Identification and sharing of 
good practice — both clinical  
and strategic
8	Identification and dissemination of 
existing resources
8	Collaborative working with the 
commercial sector
8	Encouraging and developing new 
authors both as individuals but 
also by working more closely with 
education providers
8	Focusing on education and training
8	Maintaining a strong political 
focus — addressing issues which 
challenge wound care practitioners 
across the UK.
Sharing good practice
One of the first issues the editorial 
team wish to address is the many 
areas of good practice across the UK, 
liaising closely with both regional and 
national groups to identify existing 
resources and those in development. 
In this way, it is hoped that resources 
and practices can be disseminated and 
shared, improving patient care across 
the whole of the UK. In future issues, 
we plan to provide information on 
the activities of regional and national 
groups, specifically highlighting where 
protocols and guidance have been 
developed.
the High Impact Action: Your Skin 
Matters – Technical sheet (Queen’s 
Nursing Organisation [QNI], 2010) 
specifies that in counting pressure 
ulcers it is only a healthcare-associated 
incident after 72 hours. This seems 
hugely at odds with other documents 
which propose windows of six hours 
for assessment (National Institute 
for Health and Clinical Excellence 
[NICE], 2005), and many local 
policies which state a timeframe of 
24 hours. The definition of ‘incipient’ 
pressure ulcers seems unfounded 
and is not referenced. This will have 
a huge impact on organisational data 
collection, with ‘blame’ for occurrence 
of damage being incorrectly attributed 
based on a seemingly random, time-
based definition. 
Furthermore, the whole process 
of collecting incidence data appears 
confusing and conflicting. Clinicians 
are unsure if they are counting new 
patients or new pressure ulcers, 
recording a pressure ulcer once or 
recording it at its worst category 
(which may mean counting it twice 
if the patient deteriorates). Equally, 
is re-categorising acceptable, i.e. if 
you categorise a pressure ulcer as 3 
but then slough is removed and the 
full extent of damage is visible, can 
you ‘change’ to a 4. This seems to be 
the only way as both un-stageable 
and suspected deep tissue injury 
(European Pressure Ulcer Advisory 
Panel/National Pressure Ulcer 
Advisory Panel [EPUAP/NPUAP], 
2009) are not included within UK 
definitions. The document appears to 
imply we are not counting category 
1 damage (in contradiction with what 
many organisations already collect and 
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... pressure ulcers seem 
to be high on the clinical 
agenda at present, with 
tissue viability nurses 
(TVNs) across the regions 
debating key issues  
around definitions.
Addressing challenging issues
In terms of addressing issues that 
challenge practitioners across the 
whole of the UK, pressure ulcers seem 
to be high on the clinical agenda at 
present, with tissue viability nurses 
(TVNs) across the regions debating 
key issues around definitions: what 
is avoidable/unavoidable and can 
we agree on this without having to 
undertake a root cause analysis for 
every patient who develops pressure 
damage? There are areas where there 
seems to be consistency, for example, 
the project within Scotland (www.
tissueviabilityonline.com/), yet other 
areas have little, if any agreement.
There is also concern at the 
inconsistencies across high level 
strategic documents, for example, 
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report). It does, however, specifically 
state that data on incontinence-
associated dermatitis (IAD) should not 
be included, something many clinicians 
are striving to improve as moisture 
lesions or IAD seem to be ‘lumped 
together’ with sacral pressure damage, 
despite having different causes and 
management to pressure ulcers. 
Equally, this highlights huge 
discrepancies in practice where some 
areas openly state that their data does 
not discriminate (Foxley and Baadjies, 
2010), and other areas where clinicians 
put a huge amount of effort into 
ensuring that anything that is not a 
pressure ulcer is excluded.
To many ground level clinicians, it 
seems that decisions are being taken 
without appropriate consultation, 
leading to a considerable amount 
of hard work to figure out what is 
workable and what is, in some cases, 
utter nonsense.
Focusing on education and training
The people who work in the NHS 
are among the most talented in the 
world, with other countries seeking 
to learn from our comprehensive 
system of general practice, and 
its role as the medical home for 
patients, providing continuity of care 
and coordination (Department of 
Health [DH], 2010). The coalition 
government has stated that the DH 
will have a progressively reduced role 
in overseeing education and training, 
with the new system being designed 
to ensure that education and training 
commissioning is aligned locally and 
nationally with the commissioning 
of patient care (DH, 2010). It is 
therefore vitally important that tissue 
viability practitioners develop and 
understand the healthcare needs of 
their population base, and are able to 
maintain their education and skills to 
deliver evidence-based care. 
This development of knowledge 
and skills will need to be achieved 
from a variety of sources, including 
formalised courses delivered by higher 
education institutions, local study 
days, conferences, books, journals and 
specialist practitioners. The funding 
of formalised courses may become 
difficult to access and so the effective 
development of partnerships with 
industry that do not bias the choice of 
treatment will need to be explored.
Working collaboratively with  
commercial organisations
The principles of working 
collaboratively with industry are not 
new, but many clinicians and managers 
view collaborative working with a 
degree of suspicion. In the current 
healthcare environment, where 
there are huge financial pressures, 
collaborative working can only be 
seen to be beneficial. The DH (2008) 
proposed that partnership working is at 
We look forward to working with 
you all.
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the core of improving clinically effective, 
safe, personal and high quality care. In 
future issues, we hope to highlight areas 
where working closely with industry 
can be for the benefit of all concerned 
with pooling of skills, experience and 
resources, working for mutual benefit, 
with the patient as the principal 
beneficiary (Figure 1). The DH (2008) 
suggest that creating new partnerships 
between the NHS, universities and 
industry will enable pioneering new 
treatments and models of care to be 
developed and delivered directly to 
patients. We will be looking at ways of 
working with industry and their trade 
organisations to ensure that the best 
and most cost-effective care is available 
to patients.
Wounds UK strives to be a forward-
thinking, clinically useful journal. By 
focusing on these issues, in addition 
to our usual clinical content, we hope 
to provide you with a relevant and 
meaningful resource for years to come.
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It is vitally important that 
tissue viability practitioners 
develop and understand 
the healthcare needs of 
their population base, and 
are able to maintain their 
education and skills to 
deliver evidence-based care. 
Wuk
Figure 1. Tripartite working.
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